Event

OSCO Presents “Best of” San Antonio Breast Cancer Symposium® Virtual Symposium

The Oklahoma Society of Clinical Oncology, Inc. would like to invite you to attend our 2022 Spring meeting,

Join your colleagues to hear highlights from this state-of-the art symposium on the experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease. The “Best of” SABCS is an officially licensed program of the San Antonio Breast Cancer Symposium.  This virtual symposium is directed towards Hematologists and Oncologists, Nurses, Pharmacists, Physician Assistants and other health care professionals specializing in Oncology.  This meeting will break down the most clinically relevant abstracts from the SABCS annual symposium, providing attendees to hear the latest strategies in oncology education.  Note:  There is no fee for physicians and allied health personnel to attend, but meeting registration is required.  

  • “Best of” SABCS®” is an officially licensed program provided through Encore Medical Education.
  • This conference is jointly provided by Postgraduate Institute for Medicine and Oklahoma Society of Clinical Oncology, Inc.
  • This activity has been approved for a maximum of 3.5 AMA PRA Category 1 Credit(s)™and 3.5 contact hours for Continuing Nursing Education.

Pharmaceutical Companies interested in Corporate Membership? Join here →

Companies interested in a virtual exhibit for Spring and/or Fall Conference? Purchase here →

Show Agenda
  • 7:30 AM (CDT)
    Virtual Exhibitor Booths Open
  • 7:50 AM - 8:00 AM (CDT)
    Welcome Remarks & Annual Member Meeting
    Jose Eugenio Najera, MD

    Jose Eugenio Najera, MD

    OSCO President

  • William Dooley, MD

    William Dooley, MD

    OSCO Treasurer

  • 8:00 AM - 8:15 AM (CDT)
    Break with Virtual Exhibitors
  • 8:15 AM - 8:35 AM (CDT)
    One Week of Whole Breast Radiotherapy As the New Standard of Care - Speaker 1
    Professor Charlotte Coles, MBChB, MRCP, FRCR, PhD

    Professor Charlotte Coles, MBChB, MRCP, FRCR, PhD

    Breast Cancer Clinical Oncology and Deputy Health of Department of Oncology

    University of Cambridge, United Kingdom

  • 8:35 - 8:55
    One Week of Whole Breast Radiotherapy As the New Standard of Care - Speaker 2
    Christina E. Henson, MD

    Christina E. Henson, MD

    Assistant Professor, Department of Radiation Oncology

    Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma

  • 8:55 AM - 9:10 AM (CDT)
    Q&A with Professor Coles
  • 9:10 AM - 9:25 AM (CDT)
    Break with Virtual Exhibitors
  • 9:25 AM - 10:20 AM (CDT)
    Genomic Profiling in Early-Stage ER Positive Breast Cancers
    Professor Mitch Dowsett, PhD, FMedSci

    Professor Mitch Dowsett, PhD, FMedSci

    Honorary Consultant Clinical Scientist at the Royal Marsden Hospital and Emeritus Professor Biochemical Endocrinology

    Institute of Cancer Research, London, United Kingdom

  • 10:20 AM - 10:35 AM (CDT)
    Break with Virtual Exhibitors
  • 10:35 AM - 11:30 AM (CDT)
    Heterogeneity of Breast Cancer Genomes
    Funmi Olopade, MD

    Funmi Olopade, MD

    Associate Dean for Global Health, Director, Center for Clinical Cancer Genetics

    University of Chicago, Chicago, Illinois

  • 11:30 AM - 11:45 AM (CDT)
    Break with Virtual Exhibitors
  • 11:45 AM - 12:40 PM (CDT)
    Where We Stand in Triple Negative Breast Cancer
    Joyce O'Shaughnessy, MD

    Joyce O'Shaughnessy, MD

    Medical Director, Breast Cancer Research Program

    Baylor University, Dallas, Texas

  • 12:40 PM (CDT)
    Adjournment